This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

Drug Discovery of the Year

Background

This award aims to show how crucial pharmacology remains in the development of new medicines, and to reward the achievements of the teams of scientists who discover new drugs.

Criteria

The award will be given to the discovery team behind a drug (large or small molecule) which is an exciting new prospect that best fulfils the following criteria:

  1. Gained regulatory approval within the last three years in the EU and/or the US.
  2. Preclinical to clinical translation shows the importance of pharmacology in the drug discovery/development process.
  3. Has a significant impact on an unmet medical need.
  4. First-in-class, or is a significant improvement over other drugs in the class.
  5. And, mechanism of action known.

Past Winners

  • 2017 - the team at GlaxoSmithKline responsible for Strimvelis
  • 2016 - the team at Gilead Sciences responsible for sofosbuvir
  • 2015 - the team at Roche responsible for obinutuzumab
  • 2014 - the team  at GlaxoSmithKline responsible for trametinib
  • 2013  - the team at Genentech responsible for vismodegib